Niagen Bioscience, Inc. - Director's Dealing 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2012-12-21

Reporting Person: Lockshin Curtis (N/A)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-21	Employee Stock Options (right to buy)	$1.54	D	67500	Disposed	2021-05-10	Common Stock (67500)	Direct
2012-12-21	Employee Stock Options (right to buy)	$0.945	A	45651	Acquired	2022-09-15	Common Stock (45651)	Direct

F1: These previously awarded options have been terminated in exchange of a new award of options under different terms.

F2: Options vested 1/12th every month for 12 months and have been fully vested as of May 10, 2012.

F3: These new options are awarded by terminating the previously awarded options under different terms.

F4: Options vest 1/12th every month for 12 months and will be fully vested on September 15, 2013.

F5: The total includes 67,500 options under different terms.